AxTalis news and insights

65 days to go until January 12, 2025

On June 20 EUnetHTA21 published the D5.4 deliverable on medicinal

𝐃𝐨 𝐲𝐨𝐮 𝐤𝐧𝐨𝐰 𝐰𝐡𝐚𝐭 𝐑𝐈𝐏 𝐫𝐞𝐚𝐥𝐥𝐲 𝐦𝐞𝐚𝐧𝐬?!

More price negotiations on new expensive drugs in the Netherlands

Recently, the Belgian Healthcare Knowledge Center (KCE) published a report

Many people working in Pharmaceutical or Medtech companies ask us

We are honoured to be joined by Sabrina Lagniau as

Arthur Vanlaethemstraat 1
9050 Gentbrugge
Belgium
BE0745.587.926

RPR Gent afdeling Gent
Supervising authority for pharmacovigilance: FAMHP
(ADR@fagg.be)

M • info@axtalis.com